“…One US study reported that treatment expenses were USD 25,000-28,000 higher per patient with VAP 5 , while the mortality rate in connection with VAP was 5%-65%, depending on the patients' condition. 3,4 VAP incidence in intensive care units (ICUs), where most patients use ventilators, has been reported to range from 8%-28% 5,6 , or 13-51/1,000 ventilator days. 7 The Respiratory Care Unit (RCU), Department of Medicine, Siriraj Hospital, provides care for patients with respiratory failure, unstable blood circulation, respiratory infections, air-borne infections, difficulty weaning from ventilators and severe complications from diagnostic procedures and treatment of respiratory illnesses.…”